Rather, we observed a trend toward a lower percentage of KR+ CD8+ T cells, which trafficked from the tumor to the dLN at this timepoint (4 days after CAN-2409 treatment and 2 days after photoconversion). This evidence concerns the gene CD8A and neoplasm.